NTRA logo

Natera Inc (NTRA)

Natera, Inc., a diagnostics company, engages in the development and commercialization of molecular testing services worldwide. It offers Signatera, a personalized ctDNA blood test for MRD assessment, early recurrence monitoring, and evaluation of treatment response in patients previously diagnosed with cancer; Latitude, a blood-based MRD test for colorectal...

NASDAQHealthcareDiagnostics & ResearchUSA

公司简介

股票代码
NTRA
ISIN代码
US6323071042
货币
US Dollar (USD)
IPO日期
2015-07-02

联系信息

公司地址
13011 McCallen Pass, Austin, TX, United States, 78753
联系电话
650 980 9190
公司网站
https://www.natera.com
财年结束
December

财务亮点

市值
$999,999.99
毛利润(TTM)
$999,999.99
资产回报率(TTM)
-8.08%
EBITDA
$-999,999.99
收入(TTM)
$999,999.99